Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial

Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-10-31T19:33:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice appears announcing that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.2%
    Check dated 2026-10-24T20:30:56.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new version of the lupus clinical trial record was submitted on October 14, 2026, and posted October 15, with updates to study status and contacts/locations.
    Difference
    0.2%
    Check dated 2026-10-17T22:05:06.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision label updated from v3.7.0 to v3.7.1, while the clinical study record history remained unchanged.
    Difference
    0.0%
    Check dated 2026-10-10T22:09:26.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A new study-record version dated 2026-10-02 was added, documenting updates to the study status and contacts/locations. The history also reflects a date change around the prior version.
    Difference
    0.2%
    Check dated 2026-10-03T21:52:33.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-09-19T19:12:50.000Z thumbnail image

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.